The in vivo efficacy and side effect pharmacology of GS‐5759, a novel bifunctional phosphodiesterase 4 inhibitor and long‐acting β2‐adrenoceptor agonist in preclinical animal species
Salmon, Michael, Tannheimer, Stacey L., Gentzler, Terry T., Cui, Zhi‐Hua, Sorensen, Eric A., Hartsough, Kimberly C., Kim, Musong, Purvis, Lafe J., Barrett, Edward G., McDonald, Jacob D., Rudolph, Karin, Doyle‐Eisele, Melanie, Kuehl, Philip J., Royer, Christopher M., Baker, William R., Phillips, Gary B., Wright, Clifford D.
Published in Pharmacology research & perspectives (01.08.2014)
Published in Pharmacology research & perspectives (01.08.2014)
Get full text
Journal Article
The in vivo efficacy and side effect pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long-acting β 2-adrenoceptor agonist in preclinical animal species
Salmon, Michael, Tannheimer, Stacey L, Gentzler, Terry T, Cui, Zhi-Hua, Sorensen, Eric A, Hartsough, Kimberly C, Kim, Musong, Purvis, Lafe J, Barrett, Edward G, McDonald, Jacob D, Rudolph, Karin, Doyle-Eisele, Melanie, Kuehl, Philip J, Royer, Christopher M, Baker, William R, Phillips, Gary B, Wright, Clifford D
Published in Pharmacology research & perspectives (01.08.2014)
Published in Pharmacology research & perspectives (01.08.2014)
Get full text
Journal Article